County of Los AngelesHealth AgencyDept of Health ServicesOlive View-UCLA Medical CenterDept of Medicine

Archive of Didactics in diabetes mellitus

Sep 19 2017

Reduced Cardiovascular and Renal Events with Canaglifozin (CANVAS + CANVAS-R)

EBM, Journal Club

Presented by Alex Zhornitskiy, M.D.

Moderated by Vinhfield Ta, M.D.

Thank you, Alex, for a review of outcome data for one of the newest diabetes medications: canaglifozin (Invokana®).  Canaglifozin is a SGLT2 inhibitor, which decreases reabsorption of glucose in the renal tubules. Clinical Question: Among patients with DM2 at high risk…

Clinical Topics:

Read more
Back To Top
Login
Log in below to access learning modules.
Forgot Password?
Forgot Password
Enter your email address or username and we’ll send you instructions to reset your password.